Status Finished Effective start/end date 1/12/22 → 1/12/23
RNA Binding Protein
Pharmacology, Toxicology and Pharmaceutical Science
100%
Structural Protein
Pharmacology, Toxicology and Pharmaceutical Science
100%
Severe Acute Respiratory Syndrome
Pharmacology, Toxicology and Pharmaceutical Science
100%
SARS Coronavirus
Pharmacology, Toxicology and Pharmaceutical Science
40%
Viral Protein
Pharmacology, Toxicology and Pharmaceutical Science
40%
Pandemic
Pharmacology, Toxicology and Pharmaceutical Science
20%
Single Stranded RNA
Pharmacology, Toxicology and Pharmaceutical Science
20%
Remdesivir
Pharmacology, Toxicology and Pharmaceutical Science
20%